Liquidia Corporation logo

Liquidia Corporation

NASDAQ:LQDA

Overview | Financials
Company Name Liquidia Corporation
Symbol LQDA
Currency USD
Price 9.91
Market Cap 825,051,104
Dividend Yield 0%
52-week-range 5.71 - 16.99
Industry Biotechnology
Sector Healthcare
CEO Dr. Roger A. Jeffs Ph.D.
Website https://www.liquidia.com

An error occurred while fetching data.

About Liquidia Corporation

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation

Related Stocks

The Joint Corp. logo

The Joint Corp.

JYNT

11.47 USD

Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc.

VYGR

6.23 USD

Verastem, Inc. logo

Verastem, Inc.

VSTM

2.71 USD

MacroGenics, Inc. logo

MacroGenics, Inc.

MGNX

3.3 USD

Viemed Healthcare, Inc. logo

Viemed Healthcare, Inc.

VMD

7.39 USD

Financials

Numbers are in millions USD

Numbers are in millions USD